Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial

被引:53
作者
von Blanckenburg, Pia [1 ]
Schuricht, Franziska [1 ]
Albert, Ute-Susann [2 ]
Rief, Winfried [1 ]
Nestoriuc, Yvonne [3 ]
机构
[1] Univ Marburg, Dept Clin Psychol & Psychotherapy, D-35032 Marburg, Germany
[2] Univ Marburg, Breast Canc Ctr, Dept Gynecol Gynecol Endocrinol & Oncol, D-35032 Marburg, Germany
[3] Univ Hamburg, Dept Clin Psychol, Hamburg, Germany
关键词
Nocebo; Side effects; Prevention; Breast cancer; Endocrine therapy; RCT; ADJUVANT HORMONAL-THERAPY; EUROPEAN-ORGANIZATION; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; COMBINATION TRIAL; CLINICAL-TRIALS; ATAC ARIMIDEX; SHORT-FORM; ADHERENCE; QUESTIONNAIRE;
D O I
10.1186/1471-2407-13-426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Adjuvant endocrine therapy can improve disease-free survival and time before recurrence in breast cancer patients. However, it is associated with considerable side effects that negatively affect patients' quality of life and cause non-adherence. The recently demonstrated effect of individual expectations on side-effect development (nocebo effect) suggests that psychological factors play a role in the prevention of side effects. The aim of this study is to evaluate cognitive-behavioral side-effect prevention training (SEPT) for breast cancer patients. This article describes the study protocol and applied research methods. Methods/Design: In a randomized controlled trial, 184 female breast cancer patients are assigned to receive either SEPT, standard medical care or a manualized supportive therapy at the start of adjuvant endocrine treatment. SEPT consists of three sessions of cognitive-behavioral training including psychoeducation to provide a realistic view of endocrine therapy, imagination-training to integrate positive aspects of medication into daily life, and side-effect management to enhance expectations about coping ability. Side effects three months after the start of endocrine therapy serve as primary outcomes. Secondary outcomes include quality of life, coping ability and patients' medication adherence. Patients' expectations (i.e., expectations about side effects, coping ability, treatment and illness) are analyzed as mediators. Discussion: The optimization of expectations might be a potential pathway in health care to improve patients' quality of life during long-term medication intake. The results will provide implications for a possible integration of evidence-based prevention training into clinical practice.
引用
收藏
页数:10
相关论文
共 62 条
  • [21] Placebo and Nocebo Effects in Randomized Double-Blind Clinical Trials of Agents for the Therapy for Fatigue in Patients With Advanced Cancer
    de la Cruz, Maxine
    Hui, David
    Parsons, Henrique A.
    Bruera, Eduardo
    [J]. CANCER, 2010, 116 (03) : 766 - 774
  • [22] Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
    Demissie, S
    Silliman, RA
    Lash, TL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 322 - 328
  • [23] Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
    Dowsett, Mitch
    Cuzick, Jack
    Ingle, Jim
    Coates, Alan
    Forbes, John
    Bliss, Judith
    Buyse, Marc
    Baum, Michael
    Buzdar, Aman
    Colleoni, Marco
    Coombes, Charles
    Snowdon, Claire
    Gnant, Michael
    Jakesz, Raimund
    Kaufmann, Manfred
    Boccardo, Francesco
    Godwin, Jon
    Davies, Christina
    Peto, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 509 - 518
  • [24] Efficacy of Cognitive Behavioral Therapy and Physical Exercise in Alleviating Treatment-Induced Menopausal Symptoms in Patients With Breast Cancer: Results of a Randomized, Controlled, Multicenter Trial
    Duijts, Saskia F. A.
    van Beurden, Marc
    Oldenburg, Hester S. A.
    Hunter, Myra S.
    Kieffer, Jacobien M.
    Stuiver, Martijn M.
    Gerritsma, Miranda A.
    Menke-Pluymers, Marian B. E.
    Plaisier, Peter W.
    Rijna, Herman
    Cardozo, Alexander M. F. Lopes
    Timmers, Gertjan
    van der Meij, Suzan
    van der Veen, Henk
    Bijker, Nina
    de Widt-Levert, Louise M.
    Geenen, Maud M.
    Heuff, Gijsbert
    van Dulken, Eric J.
    Boven, Epie
    Aaronson, Neil K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (33) : 4124 - 4133
  • [25] G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
    Faul, Franz
    Erdfelder, Edgar
    Lang, Albert-Georg
    Buchner, Axel
    [J]. BEHAVIOR RESEARCH METHODS, 2007, 39 (02) : 175 - 191
  • [26] From despair to hope: Alongitudinal study of illness perceptions and coping in a psycho-educational group intervention for women with breast cancer
    Fischer, Maarten J.
    Wiesenhaan, Marion E.
    Does-den Heijer, Aukje
    Kleijn, Wim C.
    Nortier, Johan W. R.
    Kaptein, Adrian A.
    [J]. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2013, 18 (03) : 526 - 545
  • [27] Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
    Gibson, Lorna
    Lawrence, David
    Dawson, Claire
    Bliss, Judith
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [28] Cancer survivors' and employers' perceptions of working following cancer treatment
    Grunfeld, E. A.
    Low, E.
    Cooper, A. F.
    [J]. OCCUPATIONAL MEDICINE-OXFORD, 2010, 60 (08): : 611 - 617
  • [29] Adherence beliefs among breast cancer patients taking tamoxifen
    Grunfeld, EA
    Hunter, MS
    Sikka, P
    Mittal, S
    [J]. PATIENT EDUCATION AND COUNSELING, 2005, 59 (01) : 97 - 102
  • [30] Stress response syndromes in women undergoing mammography: A comparison of women with and without a history of breast cancer
    Gurevich, M
    Devins, GM
    Wilson, C
    McCready, D
    Marmar, CR
    Rodin, GM
    [J]. PSYCHOSOMATIC MEDICINE, 2004, 66 (01): : 104 - 112